INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
HOUSE PTR/Partial saleVerified data

Thomas H. Kean, Jr. sold JNJ

Self · JOHNSON & JOHNSON · Johnson & Johnson Common Stock

Side
SELL
Value range
$15K – $50K
Shares
Not disclosed
Price
—
Executed
Jan 23, 2026
Disclosed
Feb 19, 2026
Disclosure timeline27 days from execution to publication · legal deadline 45 days
Jan 23 executedFeb 19, 2026 disclosed

JNJ · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
24/ 100 · ROUTINE
Methodology →
  • Transaction type+10 / 20

    Partial sale

  • Relative size+6 / 25

    Disclosed range starting at $15K

  • Filing timing0 / 15

    Disclosed 27 days after execution (STOCK Act deadline: 45)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · JNJ

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    16
    Thomas H. Kean, Jr.RSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KSep 30, 2026Oct 30, 2026
    traded Sep 30, 2026
    		+30dHOUSE PTR

    Evidence

    20
    Lloyd DoggettDSelf
    JNJJOHNSON & JOHNSON
    Purchase
    		BUY$1,001 – $15KSep 8, 2026Oct 5, 2026
    traded Sep 8, 2026
    		+27dHOUSE PTR

    Evidence

    16
    Thomas H. Kean, Jr.RSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KAug 27, 2026Sep 12, 2026
    traded Aug 27, 2026
    		+16dHOUSE PTR

    Evidence

    16
    RM
    Richard Dean McCormickSelf
    JNJJOHNSON & JOHNSON
    Sale
    		SELL$1,001 – $15KJul 30, 2026Aug 14, 2026
    traded Jul 30, 2026
    		+15dHOUSE PTR

    Evidence

    20
    Thomas H. Kean, Jr.RSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KJun 2, 2026Jul 15, 2026
    traded Jun 2, 2026
    		+43dHOUSE PTR

    Evidence

    16
    Thomas H. Kean, Jr.RSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KJun 29, 2026Jul 15, 2026
    traded Jun 29, 2026
    		+16dHOUSE PTR

    Evidence

    20
    Lloyd DoggettDSelf
    JNJJOHNSON & JOHNSON
    Purchase
    		BUY$1,001 – $15KJun 9, 2026Jul 6, 2026
    traded Jun 9, 2026
    		+27dHOUSE PTR

    Evidence

    21
    Thomas H. Kean, Jr.RSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KMar 26, 2026Apr 13, 2026
    traded Mar 26, 2026
    		+18dHOUSE PTR

    Evidence

    25
    RM
    Richard Dean McCormickSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KMar 19, 2026Apr 7, 2026
    traded Mar 19, 2026
    		+19dHOUSE PTR

    Evidence

    25
    RM
    Richard Dean McCormickSelf
    JNJJOHNSON & JOHNSON
    Partial sale
    		SELL$1,001 – $15KMar 19, 2026Apr 7, 2026
    traded Mar 19, 2026
    		+19dHOUSE PTR

    Evidence

    24
    Lloyd DoggettDSelf
    JNJJOHNSON & JOHNSON
    Purchase
    		BUY$1,001 – $15KMar 10, 2026Apr 6, 2026
    traded Mar 10, 2026
    		+27dHOUSE PTR

    Evidence

    30
    ST
    Schmid TimothyEVP, WW Chair, MedTech
    JNJJOHNSON & JOHNSON
    Option exercise
    		M$1.59M
    15.6K sh
    		Feb 6, 2026Feb 10, 2026
    traded Feb 6, 2026
    		+4dSEC FORM 4

    Evidence

    30
    ST
    Schmid TimothyEVP, WW Chair, MedTech
    JNJJOHNSON & JOHNSON
    Tax withholding
    		F$2.48M
    10.3K sh
    		Feb 6, 2026Feb 10, 2026
    traded Feb 6, 2026
    		+4dSEC FORM 4

    Evidence

    18
    ST
    Schmid TimothyEVP, WW Chair, MedTech
    JNJJOHNSON & JOHNSON
    Option exercise
    		M$1.59M
    15.6K sh
    		Feb 6, 2026Feb 10, 2026
    traded Feb 6, 2026
    		+4dSEC FORM 4

    Evidence

    30
    FE
    Forminard ElizabethEVP, Chief Legal Officer
    JNJJOHNSON & JOHNSON
    Tax withholding
    		F$1.48M
    6,226 sh
    		Feb 5, 2026Feb 6, 2026
    traded Feb 5, 2026
    		+1dSEC FORM 4

    Evidence

    30
    FE
    Forminard ElizabethEVP, Chief Legal Officer
    JNJJOHNSON & JOHNSON
    Option exercise
    		M$1.16M
    8,921 sh
    		Feb 5, 2026Feb 6, 2026
    traded Feb 5, 2026
    		+1dSEC FORM 4

    Evidence

    18
    FE
    Forminard ElizabethEVP, Chief Legal Officer
    JNJJOHNSON & JOHNSON
    Option exercise
    		M$1.16M
    8,921 sh
    		Feb 5, 2026Feb 6, 2026
    traded Feb 5, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20034025

    Timestamps

    Event (reported)
    Jan 23, 2026
    Published
    Feb 19, 2026
    Ingested by INSIDER
    Nov 5, 06:47 UTC
    Last re-read
    Nov 5, 06:47 UTC

    Extracted facts

    Filer
    Thomas H. Kean, Jr.
    Role
    Self
    Transaction
    Partial saleAs filed: “S (partial)”
    Asset
    Johnson & Johnson Common Stock
    Ticker
    JNJ
    Reported value
    $15K – $50KAs filed: “$15,001 - $50,000”
    Execution date (reported)
    Jan 23, 2026
    Notification date (reported)
    Feb 5, 2026
    Days from execution to publication
    27

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $15,001
    • High: $50,000

    = $32,501

    What this establishes

    Thomas H. Kean, Jr. reported a partial sale of Johnson & Johnson Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    Thomas H. Kean, Jr.bioguide:K000398
    Issuer
    JOHNSON & JOHNSONcik:0000200406

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.